Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Grimm, Simone [VerfasserIn]   i
 Keicher, Christian [VerfasserIn]   i
 Paret, Christian [VerfasserIn]   i
 Niedtfeld, Inga [VerfasserIn]   i
 Beckmann, Christian [VerfasserIn]   i
 Mennes, Maarten [VerfasserIn]   i
 Just, Stefan [VerfasserIn]   i
 Sharma, Vikas [VerfasserIn]   i
 Fuertig, René [VerfasserIn]   i
 Herich, Lena [VerfasserIn]   i
 Mack, Salome [VerfasserIn]   i
 Thamer, Claus [VerfasserIn]   i
 Schultheis, Christian [VerfasserIn]   i
 Weigand, Anne [VerfasserIn]   i
 Schmahl, Christian [VerfasserIn]   i
 Wunder, Andreas [VerfasserIn]   i
Titel:The effects of transient receptor potential cation channel inhibition by BI 1358894 on cortico-limbic brain reactivity to negative emotional stimuli in major depressive disorder
Verf.angabe:Simone Grimm, Christian Keicher, Christian Paret, Inga Niedtfeld, Christian Beckmann, Maarten Mennes, Stefan Just, Vikas Sharma, René Fuertig, Lena Herich, Salome Mack, Claus Thamer, Christian Schultheis, Anne Weigand, Christian Schmahl, Andreas Wunder
E-Jahr:2022
Jahr:4 November 2022
Umfang:8 S.
Fussnoten:Online verfügbar: 4 November 2022, Artikelversion: 4 November 2022 ; Gesehen am 06.06.2023
Titel Quelle:Enthalten in: European neuropsychopharmacology
Ort Quelle:Amsterdam : Elsevier, 1990
Jahr Quelle:2022
Band/Heft Quelle:65(2022) vom: Dez., Seite 44-51
ISSN Quelle:1873-7862
Abstract:Abnormal emotional processing in major depressive disorder (MDD) has been associated with increased activation to negative stimuli in cortico-limbic brain regions. The authors investigated whether treatment with BI 1358894, a small-molecule inhibitor of the transient receptor potential cation channel subfamily C leads to attenuated activity in these areas in MDD patients. 73 MDD patients were randomized to receive a single oral dose of BI 1358894 (100 mg), citalopram (20 mg), or matching placebo. Brain responses to emotional faces and scenes were investigated using functional magnetic resonance imaging. Primary endpoints were BOLD signal changes in response to negative faces in cortico-limbic brain regions, i.e. bilateral amygdala (AMY), dorsolateral prefrontal cortex, anterior insula (AI), and anterior cingulate cortex. Secondary endpoints were BOLD signal changes in response to negative scenes. For each region, separate ANOVA models were computed for the comparison of treatments (BI 1358894 or citalopram) vs. placebo. The adjusted treatment differences in the % BOLD signal changes in the faces task showed that BI 1358894 induced signal reduction in bilateral AMY and left AI. In the scenes task, BI 1358894 demonstrated significant signal reduction in bilateral AMY, AI, anterior cingulate cortex and left dorsolateral prefrontal cortex. Citalopram failed to induce any significant reductions in BOLD signal in both tasks. BI 1358894-mediated inhibition of the transient receptor potential cation channel subfamily resulted in strong signal reduction in cortico-limbic brain regions, thereby supporting development of this mechanism of action for MDD patients.
DOI:doi:10.1016/j.euroneuro.2022.10.009
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.1016/j.euroneuro.2022.10.009
 Volltext: https://www.sciencedirect.com/science/article/pii/S0924977X22008859
 DOI: https://doi.org/10.1016/j.euroneuro.2022.10.009
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:Citalopram
 Cortico-limbic brain areas
 Emotional processing
 Major depressive disorder
 TRPC inhibition
K10plus-PPN:1847458394
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69082705   QR-Code
zum Seitenanfang